Inhibitory effects of sesamin on human osteoclastogenesis

Archives of Pharmacal Research

Volumn 40, Issue 10, 2017, Pages 1186-1196

  Wanachewin, Orawan ^a   Pothacharoen, Peraphan ^a   Kongtawelert, Prachya ^a   Phitak, Thanyaluck ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Differentiation; Osteoclast; PBMCs; Sesamin; TRAP

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2B; CHEMOKINE RECEPTOR CCR4; COLLAGEN; COLONY STIMULATING FACTOR 1; F ACTIN; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; SESAMIN; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; LIGNAN; TNFSF11 PROTEIN, HUMAN;

ARTICLE; BONE SLICE; CATHK GENE; CELL COUNT; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG STRUCTURE; ENZYME PHOSPHORYLATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAPK SIGNALING; NFATC1 GENE; OSTEOCLASTOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYTOCHEMISTRY; PROTEIN EXPRESSION; STEM CELL; TRAP GENE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; METABOLISM; NORMAL HUMAN; OSTEOCLAST; OSTEOLYSIS; PREVENTION AND CONTROL;

BONE MARROW CELLS; BONE RESORPTION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DIOXOLES; GENE EXPRESSION; HEALTHY VOLUNTEERS; HUMANS; LIGNANS; MACROPHAGE COLONY-STIMULATING FACTOR; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND;

EID: 85028766915     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-017-0926-x     Document Type: Article

References (33)

1. Asagiri M, Takayanagi H (2007) The molecular understanding of osteoclast differentiation. Bone 40(2):251–264
2. Boulbaroud S, Mesfioui A, Arfaoui A, Ouichou A, el-Hessni A (2008) Preventive effects of flaxseed and sesame oil on bone loss in ovariectomized rats. Pak J Biol Sci 11(13):1696–1701
3. Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423(6937):337–342
4. Chen M, Qiao H, Su Z, Li H, Ping Q, Zong L (2014) Emerging therapeutic targets for osteoporosis treatment. Expert Opin Therapeut Targets 18(7):817–831
5. El Wakf AM, Hassan HA, Gharib NS (2014) Osteoprotective effect of soybean and sesame oils in ovariectomized rats via estrogen-like mechanism. Cytotechnology 66(2):335–343
6. Gilchrist A, Stern PH (2015) Chemokines and Bone. Clin Rev Bone Min Metab 13(2):61–82
7. Grey A, Chen Y, Paliwal I, Carlberg K, Insogna K (2000) Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1. Endocrinology 141(6):2129–2138
8. He Y, Staser K, Rhodes SD, Liu Y, Wu X, Park S-J, Yuan J, Yang X, Li X, Jiang L (2011) Erk1 positively regulates osteoclast differentiation and bone resorptive activity. PLoS ONE. doi:10.1371/journal.pone.0024780
9. Hsieh C-C, Kuo C-H, Kuo H-F, Chen Y-S, Wang S-L, Chao D, Lee M-S, Hung C-H (2014) Sesamin suppresses macrophage-derived chemokine expression in human monocytes via epigenetic regulation. Food Funct 5(10):2494–2500
10. Ishii T, Kikuta J, Kubo A, Ishii M (2010) Control of osteoclast precursor migration: a novel point of control for osteoclastogenesis and bone homeostasis. IBMS BoneKEy 7(8):279–286
11. Kim MS, Day CJ, Morrison NA (2005) MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem 280(16):16163–16169
12. Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL (2006a) Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116(8):2152–2160
13. Kim MS, Magno CL, Day CJ, Morrison NA (2006b) Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. J Cell Biochem 97(3):512–518
14. Kim K, Lee SH, Ha Kim J, Choi Y, Kim N (2008) NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 22(1):176–185
15. Lee ZH, Kim HH (2003) Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305(2):211–214
16. Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH (2002) The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30(1):71–77
17. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408
18. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T (1998) Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246(1):199–204
19. Nakashima T, Hayashi M, Takayanagi H (2012) New insights into osteoclastogenic signaling mechanisms. Trends Endocrinol Metab 23(11):582–590
20. Phitak T, Pothacharoen P, Settakorn J, Poompimol W, Caterson B, Kongtawelert P (2012) Chondroprotective and anti-inflammatory effects of sesamin. Phytochemistry 80:77–88
21. Quinn JM, Elliott J, Gillespie MT, Martin TJ (1998) A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139(10):4424–4427
22. Roodman GD (2006) Regulation of osteoclast differentiation. Ann N Y Acad Sci 1068:100–109
23. Song I, Kim JH, Kim K, Jin HM, Youn BU, Kim N (2009) Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583(14):2435–2440
24. Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG (2006) Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro. J Cell Sci 119(Pt 7):1283–1296
25. Susa M, Luong-Nguyen NH, Cappellen D, Zamurovic N, Gamse R (2004) Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay. J Transl Med. doi:10.1186/1479-5876-2-6
26. Touaitahuata H, Planus E, Albiges-Rizo C, Blangy A, Pawlak G (2013) Podosomes are dispensable for osteoclast differentiation and migration. Eur J Cell Biol 92(4–5):139–149
27. Umeda-Sawada R, Fujiwara Y, Abe H, Seyama Y (2003) Effects of sesamin and capsaicin on the mRNA expressions of delta6 and delta5 desaturases in rat primary cultured hepatocytes. J Nutr Sci Vitaminol 49(6):442–446
28. Wanachewin O, Boonmaleerat K, Pothacharoen P, Reutrakul V, Kongtawelert P (2012) Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways. BMC Complement Altern Med. doi:10.1186/1472-6882-12-71
29. Wanachewin O, Klangjorhor J, Pothacharoen P, Phitak T, Laohapoonrungsee A, Pruksakorn D, Kongtawelert P (2015) The promoting effects of sesamin on osteoblast differentiation of human mesenchymal stem cells. J Funct Foods 14:395–406
30. Wilson SR, Peters C, Saftig P, Bromme D (2009) Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. J Biol Chem 284(4):2584–2592
31. Woessner JF Jr (1961) The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440–447
32. Wu WH, Kang YP, Wang NH, Jou HJ, Wang TA (2006) Sesame ingestion affects sex hormones, antioxidant status, and blood lipids in postmenopausal women. J Nutr 136(5):1270–1275
33. Zawawi M, Dharmapatni A, Cantley M, McHugh K, Haynes D, Crotti T (2012) Regulation of ITAM adaptor molecules and their receptors by inhibition of calcineurin-NFAT signalling during late stage osteoclast differentiation. Biochem Biophys Res Commun 427(2):404–409